United States
US 12,697,377 B2
Therapeutic anticancer neoepitope vaccine
US 12,697,377 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-04. Applicant: Nykode Therapeutics ASA. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- Nykode Therapeutics ASA
- Inventors
- Stine Granum; Elisabeth Stubsrud; Agnete Brunsvik Fredriksen
- Publication date
- 2026-08-04
- Filing date
- 2024-06-10
- Document type
- B2 Granted patent
- Also written as
- US 12,697,377 B2 · US12697377 · 12697377
Abstract
The present invention relates to an anticancer vaccine which includes polynucleotides or polypeptides, methods of treatment of cancer wherein such an anticancer vaccine is used as well as methods for producing the vaccine. The vaccine includes a polynucleotide with a nucleotide sequence encoding a targeting unit, a dimerization unit, a first linker and an antigenic unit. The antigenic unit includes from 3 to 50 antigenic subunits separated by a second linker with each antigenic subunit having at least a part of a cancer neoepitope sequence.…
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free